相关实验视频
Updated: Aug 4, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
16.0K
用强烈的脉冲光治疗皮肤莱什曼病:它是否有效?
Amirhossein Siadat1, Hamid Galehdari1, Zabiholah Shahmoradi1
1Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Advanced biomedical research
|July 12, 2023
概括
强脉冲光 (IPL) 结合内伤性葡萄糖胺显示皮肤雷什曼病 (CL) 的愈合速度比单独使用葡萄糖胺更快. 需要进一步的研究来确认IPL.
科学领域:
- 皮肤病学 皮肤病学
- 传染性疾病 传染性疾病
- 医疗技术 医疗技术 医学技术
背景情况:
- 皮肤莱什曼病 (CL) 是一种广泛的寄生虫性皮肤感染.
- 五价抗化合物是主要的治疗方法,但疗效不同.
- 针对CL的新型治疗方法正在研究中.
研究的目的:
- 为了评估强烈脉冲光 (IPL) 与内伤性葡萄糖抗剂结合用于CL治疗的疗效.
- 为了比较组合疗法的愈合速度和整体有效性,与单独的葡萄糖抗剂相比.
主要方法:
- 进行了一项随机的单盲临床试验.
- 纳入了54名确诊的CL患者.
- 治疗涉及内血糖抗剂,其中一组接受额外的每周IPL疗程长达8周.
主要成果:
- 组合疗法显示出效率更高的趋势,尽管在统计学上并不显著 (P > 0.05).
- 与单独服用葡萄糖抗剂相比,在接受IPL加上内伤性葡萄糖抗剂的组中观察到明显更快的愈合速度.
- 在这两组治疗中都没有报告任何不良副作用.
结论:
- IPL与内伤性葡萄糖抗剂相结合可能会加速皮肤莱什曼病的愈合.
- 建议使用各种IPL过器进行更大规模的研究来验证这些发现.
- IPL为CL提供了潜在的辅助疗法.
相关概念视频
Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

